These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16183482)

  • 21. [Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1 phase II trial].
    Mornex F; Girard N; Merle P; Béziat C; Kubas A; Wautot V; Khodri M; Trepo C
    Cancer Radiother; 2005 Nov; 9(6-7):470-6. PubMed ID: 16219480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description.
    Cheng JC; Wu JK; Huang CM; Huang DY; Cheng SH; Lin YM; Jian JJ; Yang PS; Chuang VP; Huang AT
    Radiother Oncol; 2002 Apr; 63(1):41-5. PubMed ID: 12065102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma.
    Yoon HI; Koom WS; Lee IJ; Jeong K; Chung Y; Kim JK; Lee KS; Han KH; Seong J
    Liver Int; 2012 Aug; 32(7):1165-71. PubMed ID: 22435801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
    Semenenko VA; Li XA
    Phys Med Biol; 2008 Feb; 53(3):737-55. PubMed ID: 18199912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of radiation-induced liver disease using the Lyman NTCP model.
    Dawson LA; Normolle D; Balter JM; McGinn CJ; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):810-21. PubMed ID: 12095546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Hepatitis B Virus Reactivation After Radiotherapy in Patients With Hepatocellular Carcinoma Using the Lyman NTCP Model.
    Li Z; Dong Y; Fan M; Yin Y; Zhu J; Li B; Huang W
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819875136. PubMed ID: 31526114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation therapy for intrahepatic malignancies.
    Quick AM; Lo SS; Mayr NA; Kim EY
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1511-21. PubMed ID: 19828012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiotherapy for unresectable hepatic malignancies.
    Ben-Josef E; Lawrence TS
    Semin Radiat Oncol; 2005 Oct; 15(4):273-8. PubMed ID: 16183481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
    Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing liver metastases with conformal radiation therapy.
    Topkan E; Onal HC; Yavuz MN
    J Support Oncol; 2008 Jan; 6(1):9-13, 15. PubMed ID: 18257395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Normal tissue tolerance to external beam radiation therapy: the stomach].
    Oberdiac P; Mineur L
    Cancer Radiother; 2010 Jul; 14(4-5):336-9. PubMed ID: 20619716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individualized image guided iso-NTCP based liver cancer SBRT.
    Dawson LA; Eccles C; Craig T
    Acta Oncol; 2006; 45(7):856-64. PubMed ID: 16982550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
    Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
    Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolving role of radiation therapy in hepatocellular carcinoma.
    Dawson LA
    Cancer Radiother; 2008 Mar; 12(2):96-101. PubMed ID: 18289910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformal chemoradiation for primary and metastatic liver malignancies.
    Dawson LA; McGinn CJ; Lawrence TS
    Semin Surg Oncol; 2003; 21(4):249-55. PubMed ID: 14648782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma: radiation therapy.
    Dawson LA; Guha C
    Cancer J; 2008; 14(2):111-6. PubMed ID: 18391616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.